Silvio Ken Garattini

Efficacy, safety, and cost of new anticancer drugs

Silvio Ken Garattini · BMJ · 2002 · 106 citations · Full text

Medicine, Oncology, Pharmacoeconomics +9

Effect of Imipramine, Amitriptyline and Their Monomethyl Derivatives on Reserpine Activity

Silvio Ken Garattini, Antonio Giachetti, A. Jori et al. · Journal of Pharmacy and Pharmacology · 1962 · 95 citations

Medicine, Pharmacology, Pharmacotherapy +8

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Sara Pusceddu, Claudio Vernieri, Massimo Di Maïo et al. · Gastroenterology · 2018 · 89 citations · Full text

Medicine, Endocrinology, Oncology +11

Cellular and molecular determinants of all‐trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression

Floriana Centritto, Gabriela Paroni, Marco Bolis et al. · EMBO Molecular Medicine · 2015 · 79 citations · Full text

Medicine, Cancer Biology, Oncology +15

The <scp>IMPACT</scp> study: early loss of skeletal muscle mass in advanced pancreatic cancer patients

Debora Basile, A. Parnofiello, Maria Grazia Vitale et al. · Journal of Cachexia Sarcopenia and Muscle · 2019 · 79 citations · Full text

Medicine, Oncology, Radiology +13